查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1701961

2025 年至 2033 年血漿分餾市場報告（按產品、產業、應用、最終用戶和地區）

Plasma Fractionation Market Report by Product, Sector, Application, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

2024年全球血漿分離市場規模達264億美元。展望未來，預計2033年市場規模將達到414億美元，2025-2033年期間的成長率（CAGR）為4.86%。慢性病盛行率的上升、技術進步以及醫療保健投資的增加是推動市場成長的一些主要因素。

血漿分餾是指將捐贈血漿進行下游加工，製成救命的療法和藥品。它使用機械分離方法（例如離心、深層過濾、沉澱和色譜法）將血漿分解成單一蛋白質或血漿級分。如今，幾種現代分餾過程利用酒精濃度、時間、溫度和 pH 值來提取特定的治療性蛋白質。此外，多年來技術複雜性的不斷增加以及過程中病毒減少治療的引入促進了新蛋白質療法的開發以及產品純度和品質的提高。

血漿分餾市場趨勢：

從人類血漿中分離出的蛋白質產品是一類重要的治療藥物，廣泛用於預防、控制和治療危及生命的疾病，例如感染、先天性缺陷、罕見血液疾病、免疫疾病和自體免疫疾病。全球相當一部分人口中這些疾病的盛行率顯著上升是推動市場成長的關鍵因素之一。此外，由於許多國家的管理機構對生物製品的品質保證實施了嚴格的規定和標準控制和設置，製造商正在開發具有額外安全功能的血漿分餾。除此之外，市場參與者正在資助研發（R&D）活動，以推動血漿生產技術的進步，提高產品功效並增強免疫球蛋白G（IgG）的回收率，從而分離新的血漿蛋白。此外，他們也致力於開發價格合理的病毒去活化和處理技術，以便安全利用當地的血漿資源。這與不斷成長的提高產量、保持製程經濟性以及管理日益增加的監管要求的需求相結合，預計將在未來幾年提供良好的市場前景。

本報告回答的關鍵問題

  • 2024 年全球血漿分餾市場規模為何？ 2025 年至 2033 年期間全球血漿分餾市場的預期成長率為何？
  • COVID-19 對全球血漿分餾市場有何影響？
  • 推動全球血漿分餾市場發展的關鍵因素有哪些？
  • 根據產品，全球血漿分餾市場是如何分佈的？
  • 全球血漿分離市場按產業分類的分佈如何？
  • 根據應用，全球血漿分餾市場是如何分佈的？
  • 根據最終用戶，全球血漿分餾市場是如何分佈的？
  • 全球血漿分餾市場的主要區域有哪些？
  • 全球血漿分餾市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球血漿分餾市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品

  • 免疫球蛋白
  • 白蛋白
  • 凝血因子Ⅷ
  • 凝血因子 IX

第7章：市場區隔：依行業

  • 私部門
  • 公部門

第 8 章：市場區隔：按應用

  • 神經病學
  • 免疫學
  • 血液學
  • 其他應用

第9章：市場區隔：依最終用戶

  • 醫院和診所
  • 臨床研究實驗室
  • 學術機構

第10章：市場細分：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • ADMA Biologics
    • Bio Products Laboratory Ltd.
    • Boccard
    • Grifols, SA
    • Hemarus Therapeutics Limited
    • Intas Pharmaceuticals Limited
    • LFB SA
    • Merck Group
    • Octapharma AG
    • PlasmaGen BioSciences Pvt. Ltd.
    • SK Plasma Co. Ltd.
    • Virchow Biotech Private Limited
Product Code: SR112025A5973

The global plasma fractionation market size reached USD 26.4 Billion in 2024. Looking forward, the market is expected to reach USD 41.4 Billion by 2033, exhibiting a growth rate (CAGR) of 4.86% during 2025-2033. The rising prevalence of chronic diseases, technological advancements, and the increasing investment in healthcare are some of the major factors driving the market growth.

Plasma fractionation refers to the downstream processing of donated plasma into life-saving therapies and medicinal products. It breaks plasma into individual proteins or plasma fractions using mechanical separation methods, such as centrifugation, depth filtration, precipitation, and chromatography. Nowadays, several modern fractionation processes use alcohol concentrations, time, temperature, and pH to extract specific therapeutic proteins. Moreover, increasing technology complexity over the years and the introduction of in-process viral reduction treatments have resulted in the development of new protein therapeutics and improvement in product purity and quality.

Plasma Fractionation Market Trends:

Protein products fractionated from human plasma are an essential class of therapeutics widely used to prevent, manage, and treat life-threatening conditions, such as infections, congenital deficiencies, rare blood disorders, immunologic disorders, and autoimmune disorders. A significant rise in the prevalence of these conditions among a significant part of the population globally represents one of the key factors impelling the market growth. In addition, manufacturers are developing plasma fractionation with additional safety features due to the implementation of stringent regulations and standard controls and settings by governing agencies of numerous countries on quality assurance of biological products. Apart from this, market players are financing research and development (R&D) activities to launch advancement in plasma production technology to improve product efficacy and enhance recovery of immunoglobulin G (IgG) to isolate new plasma proteins. Furthermore, they are focusing on developing affordable viral inactivation and processing technologies that allow utilization of local plasma resources safely. This, in confluence with the escalating need to improve yield, maintain process economics, and manage increasing regulatory requirements, is anticipated to provide a favorable market outlook in the coming years.

Key Market Segmentation:

Breakup by Product:

  • Immunoglobulins
  • Albumin
  • Coagulation factor VIII
  • Coagulation factor IX

Breakup by Sector:

  • Private Sector
  • Public Sector

Breakup by Application:

  • Neurology
  • Immunology
  • Hematology
  • Other Applications

Breakup by End User:

  • Hospitals and Clinics
  • Clinical Research Laboratories
  • Academic Institutes

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being ADMA Biologics, Bio Products Laboratory Ltd., Boccard, Grifols, S.A., Hemarus Therapeutics Limited, Intas Pharmaceuticals Limited, LFB S.A., Merck Group, Octapharma AG, PlasmaGen BioSciences Pvt. Ltd., SK Plasma Co. Ltd. and Virchow Biotech Private Limited.

Key Questions Answered in This Report

  • 1.What was the size of the global plasma fractionation market in 2024?
  • 2.What is the expected growth rate of the global plasma fractionation market during 2025-2033?
  • 3.What has been the impact of COVID-19 on the global plasma fractionation market?
  • 4.What are the key factors driving the global plasma fractionation market?
  • 5.What is the breakup of the global plasma fractionation market based on the product?
  • 6.What is the breakup of the global plasma fractionation market based on the sector?
  • 7.What is the breakup of the global plasma fractionation market based on the application?
  • 8.What is the breakup of the global plasma fractionation market based on the end user?
  • 9.What are the key regions in the global plasma fractionation market?
  • 10.Who are the key players/companies in the global plasma fractionation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Plasma Fractionation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Immunoglobulins
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Albumin
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Coagulation factor VIII
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Coagulation factor IX
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Sector

  • 7.1 Private Sector
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Public Sector
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Neurology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Immunology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hematology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Other Applications
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinical Research Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Academic Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 ADMA Biologics
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
    • 15.3.2 Bio Products Laboratory Ltd.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Boccard
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Grifols, S.A.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Hemarus Therapeutics Limited
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Intas Pharmaceuticals Limited
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 LFB S.A.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Merck Group
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Octapharma AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 SWOT Analysis
    • 15.3.10 PlasmaGen BioSciences Pvt. Ltd.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 SK Plasma Co. Ltd.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Virchow Biotech Private Limited
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Plasma Fractionation Market: Major Drivers and Challenges
  • Figure 2: Global: Plasma Fractionation Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Plasma Fractionation Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Plasma Fractionation Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Plasma Fractionation Market: Breakup by Sector (in %), 2024
  • Figure 6: Global: Plasma Fractionation Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Plasma Fractionation Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Plasma Fractionation Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Plasma Fractionation (Immunoglobulins) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Plasma Fractionation (Immunoglobulins) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Plasma Fractionation (Albumin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Plasma Fractionation (Albumin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Plasma Fractionation (Coagulation factor VIII) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Plasma Fractionation (Coagulation factor VIII) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Plasma Fractionation (Coagulation factor IX) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Plasma Fractionation (Coagulation factor IX) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Plasma Fractionation (Private Sector) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Plasma Fractionation (Private Sector) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Plasma Fractionation (Public Sector) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Plasma Fractionation (Public Sector) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Plasma Fractionation (Neurology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Plasma Fractionation (Neurology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Plasma Fractionation (Immunology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Plasma Fractionation (Immunology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Plasma Fractionation (Hematology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Plasma Fractionation (Hematology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Plasma Fractionation (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Plasma Fractionation (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Plasma Fractionation (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Plasma Fractionation (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Plasma Fractionation (Clinical Research Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Plasma Fractionation (Clinical Research Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Plasma Fractionation (Academic Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Plasma Fractionation (Academic Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: North America: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: North America: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: United States: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: United States: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Canada: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Canada: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Asia-Pacific: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Asia-Pacific: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: China: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: China: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Japan: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Japan: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: India: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: India: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: South Korea: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: South Korea: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Australia: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Australia: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Indonesia: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Indonesia: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Others: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Others: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Europe: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Europe: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Germany: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Germany: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: France: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: France: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: United Kingdom: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: United Kingdom: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Italy: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Italy: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Spain: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Spain: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Russia: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Russia: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Others: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Others: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Latin America: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Latin America: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Brazil: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Brazil: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Mexico: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Mexico: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Others: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Others: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Middle East and Africa: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Middle East and Africa: Plasma Fractionation Market: Breakup by Country (in %), 2024
  • Figure 83: Middle East and Africa: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Global: Plasma Fractionation Industry: SWOT Analysis
  • Figure 85: Global: Plasma Fractionation Industry: Value Chain Analysis
  • Figure 86: Global: Plasma Fractionation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Plasma Fractionation Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Plasma Fractionation Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Plasma Fractionation Market Forecast: Breakup by Sector (in Million USD), 2025-2033
  • Table 4: Global: Plasma Fractionation Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Plasma Fractionation Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Plasma Fractionation Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Plasma Fractionation Market: Competitive Structure
  • Table 8: Global: Plasma Fractionation Market: Key Players